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Abstract 
Chronic arthritis may have great impact on the 
patient but also on his or her family, relatives and 
friends. The assessment of the consequences of 
chronic arthritis and the effect of therapy not only 
in terms of physical, but also psychological and so- 
cial dimensions deserves more attention. Functional 
ability and health status can be measured using a 
questionnaire or ‘instrument ‘, high-lighting impor- 
tant aspects not quantified with more traditional 
measurements. In this paper, arguments to apply 
such instruments more frequently are given. Health 
status instruments can be used not only to assess 
beneficial but also deleterious (side-)effects of ther- 
apeutic interventions. The properties are summariz- 
ed of the most frequently used instruments assessing 
functional ability and health status. Many of these 
instruments have been evaluated sufficiently for va- 
lidity and reliability: their sensitivity to detect 
change seems to be satisfactory. Therefore it is ad- 
visable to choose an internationally accepted, fre- 
quently used instrument, reflecting the area of 
interest. 
Key words: Functional ability; Health status; 
Questionnaire; Instrument; Arthritis. 
Introduction and Definitions 
The effect of treatment in patients with 
rheumatic diseases, e.g. rheumatoid arthritis 
(RA), can not be assessed very easily. Since 
curing of the disease is, as yet, for most rheu- 
matic diseases not possible, treatment is prac- 
tically always aimed at alleviating symptoms. 
A gold standard to decide on the success or 
failure of a therapeutic intervention is not 
available. The course of RA is currently most 
often evaluated by using traditional measures 
of inflammation, e.g. the number of inflamed 
joints, morning stiffness and laboratory par- 
ameters like the erythrocyte sedimentation 
rate (ESR) and C-reactive protein (CRP), that 
give an idea mainly of the degree of inflamma- 
tion present (Van der Heide et al., 1992). To 
assess the consequences of joint inflamma- 
tion, function is assessed, e.g. by measuring 
grip strength, and radiographs are used to vi- 
sualize the degree of joint destruction. These 
traditional assessments of arthritis (Table 1) 
are predominantly based on physical aspects 
of the disease and are - to a more or lesser 
extent - measures of the disease process, the 
abnormal physiologic occurrences that follow 
from the cause(s) of the disease (Kirwan, 
1992). This holds especially true for clinically 
assessed joint synovitis, ESR and CRP. 
The impact (rheumatic) diseases have on 
patients is determined however not only by 
physical, but also by psychological and social 
dimensions, according to the definition of 
health of the World Health Organisation 
(WHO). The assessment also of subjective as- 
pects of health problems not addressed by 
conventional measures receives more atten- 
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Table 1. Traditional assessment of arthritis. 
A. Pain (dolor) 
0 Pain-scales: numeric rating scale, visual analogue 
scale 
??Number of analgesic tablets used 
?? Joint tenderness: articular indexes e.g. Ritchie 
score 
B. Swelling (tumor) 
??Joint circumference: jeweller’s rings 
0 Swollen joint counts 
C. Redness (ruhor) 
(Not used in trials) 
0 Inspection 
D. Temperature (calor) 
(Seldom used in trials) 
0 Palpation 
??Thermography 
E. Stiffness (rigor) 
??Duration of morning stiffness 
F. Function (functio laesa) 
??Range of motion (goniometer) 
??Grip strength 
??Walking time 
G. Other measures of inflammation 
??ESR, haemoglobin, acute-phase proteins 
??Bone scintigraphy (perfusion and diffusion 
phase) 
H. Joint destruction 
?? Radiographical scores e.g. Larsen score (Genant, 
1983). 
tion lately, not only in rheumatology but also 
in other fields of health care. This can be done 
applying a questionnaire, also called an ‘in- 
strument’. Often, these instruments are filled 
out by patients themselves: self-report, self- 
assessment or self-completed questionnaires. 
Other lists may be filled out by an observer, 
interviewer or by the rheumatologist. 
Multidimensional instruments assessing 
health may be labelled ‘health status in- 
struments’. These instruments predominantly 
address outcome of disease in contrast to the 
above mentioned traditional measures, out- 
come defined as the suffering or loss of health, 
experienced by an individual as a result of the 
process of the disease (Kirwan, 1992). In- 
struments, that address one specific aspect of 
health like psychological well-being or func- 
tional ability are called ‘dimension specific in- 
struments’; questionnaires that measure the 
value or preference patients attach to aspects 
of their health status ‘utility instruments’. 
There are ‘disease specific’ and ‘generic’ func- 
tional ability and health status instruments: 
we will go into this later. The frequently used 
terms ‘score’, ‘index’ and ‘scale’ refer to the 
method of summarizing the responses to the 
individual items of the questionnaire into a 
global score. Although it is certainly in vogue 
to use for health status questionnaires the 
synonym ‘quality of life’ instruments, it can be 
argued that the former name is more appro- 
priate, for the simple reason these instruments 
only deal with health related quality of life, 
and usually do not include aspects of quality 
of life, that have nothing to do with individual 
health care. 
This review will focus on functional ability 
and health status instruments in patients with 
RA, but it has relevance for other rheumatic 
diseases too. 
Why Should Functional Ability and Health 
Status be Assessed? 
The goal of treating an individual patient 
with RA is to alleviate symptoms and to pre- 
vent deterioration of his or her health status 
in the future. In these patients, health status is 
influenced by pain, stiffness and other signs of 
inflammation and disability with handicap 
and psychological repercussions (Fig. 1). The 
evaluation of the course and outcome of RA 
in clinical trials and observational studies by 
measuring only symptoms and signs of in- 
flammation has therefore important 
drawbacks. The picture is incomplete: dimen- 
sions like functional disability, psychological 
problems and handicap with their repercus- 
sions are not well covered. In RA, like in 
other chronic diseases, there is a considerable 
interaction between physical aspects of the 
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Fig. 1. Dimensions of chronic arthritis influencing health status*. 
Disease - Impairment _ Disability _ Handicap 
JI 
Health Status, consisting of 
A. Physical aspects, e.g. malaise, disability; pain 
B. Psychological aspects, e.g. anxiety, depression 
C. Social aspects, e.g. social integration handicap, role performance 
*Example: rheumatoid arthritis causing pain and malaise (disease), and a fixed flexion deformity of the knee (impairment), leading 
to reduction of ability to walk (disability), causing restrictions in social contacts and occupation (handicap). 
Methods to assess these dimensions e.g.: 
??Disease activity: ESR, Ritchie score (Ritchie et al., 1986) 
?? Impairment: Keitel Index (Keitel et al., 1991) 
??Disability: Stanford Health Assessment Questionnaire (Fries et al., 1980) 
??Health status: Arthritis Impact Measurement Scales (Meenan et al., 1980 and 1992) 
disease and psychological and social function- 1988). On the other hand, depression and 
ing. Functional disability can, for instance, loneliness may worsen the handicap and pain 
have an important influence on a patient’s a patient experiences. Measuring functional 
mood, and difficulty in walking can reduce ability and health status not only provides a 
people’s social contacts (Cornelissen et al., more comprehensive picture of the course of 
Table 2. Functional ability and health status instruments”. 
Generic Measures 
IWB Index of Well-Being 
RAND Rand Health Insurance Study 







Arthritis Specific Measuresb 
ARA ARA functional classification 
KATZ Katz’s index of activities of daily living 
KI Keitel Index 
LEE Lee functional status instrument 
TFCQ Toronto functional capacity questionnaire 
AIMS1 Arthritis Impact Measurement Scales 1 
HAQ Health Assessment Questionnaire 
FSI Functional Status Index 
MHIQ McMaster Health Index Questionnaire 
MACTAR McMaster Toronto Arthritis Patient 
Preference Disability Questionnaire 
ACR ACR functional classification 
AIMS2 Arthritis Impact Measurement Scales 2 
aFrequently used measures; the list is not intended to be complete. 


























RA in groups of patients, but also enables us 
to study the consequences of the disease more 
individualized. This is illustrated by the next 
example. A concert pianist with arthritis of 
one or two proximal interphalangeal joints of 
his hands has, according to traditional mea- 
sures, relatively mild RA. This “mild” disease 
however, has very serious consequences for 
the health status of our patient, since he is not 
able to work any more; probably there are 
psychological and other social consequences 
too. Thus, by applying a health status instru- 
ment, these important aspects are also assess- 
ed, which is not the case if only traditional 
measures are used. 
Also in the evaluation of efficacy of com- 
plementary and alternative treatments, that 
are widely used all over the world in patients 
with chronic rheumatic diseases, traditional 
measures give an incomplete picture. Health 
status instruments can provide a holistic eval- 
uation of complementary treatments, so that 
these treatments can be properly studied in 
clinical trials too (Jacobs et al., 1991). 
Another example. In clinical practice and 
most trials mostly clear cut side effects are 
recorded, especially if they lead to discon- 
tinuation of therapy; side effects that are not 
as serious very often play an unimportant role 
in the evaluation of the effect of drugs. This 
traditional strategy does not sufficiently eval- 
uate the impact of side effects of drugs on in- 
dividual health status. Drug side effects are 
less a problem in diseases that can be cured 
over a short time, and in cases where there are 
no alternative drugs. In chronic rheumatic 
diseases, where drugs are prescribed for long- 
er times and the disease is not cured, even ill 
defined minor drug side effects, that can be 
assessed by health status instruments, are very 
important. 
There are situations in which traditional as- 
sessment of arthritis is not only incomplete 
but even inappropriate. Health status in- 
struments can assess health problems not ad- 
dressed by traditional measures of arthritis 
nor conventional epidemiologic measures. It 
can provide appropriate data when political 
decisions have to be made regarding health 
care, medical costs and financial resources 
(Spiegelhalter et al., 1992). In this way, essen- 
tial requirements, e.g. for adequate local com- 
munity care, occupational therapy and so 
forth can be determined. For this purpose, 
health status and survival data are frequently 
combined into a single measure, e.g. the quali- 
ty adjusted life years (Fitzpatrick et al., 1992). 
The assessment of the efficacy of patient 
education and other multi-disciplinary treat- 
ment programs that are intended to augment 
self-efficacy, that is patients’ confidence that 
they can manage pain and other symptoms of 
arthritis and that they are able to perform 
tasks of daily living, cannot properly be done 
by using traditional measures of disease activ- 
ity, since these treatments are not aimed at im- 
proving disease process. Health status and 
dimension specific instruments can measure 
coping with the disease and other 
psychological and behavioral aspects. 
How Can Functional Ability and Health Status 
be Assessed? 
Patients could be asked to grade on a scale 
the health status they experience. A standard 
question, using a visual analogue scale that 
range from “very well” to “very poor” could 
be: “Considering all the ways your arthritis 
affects you, mark on the scale how well you 
are doing”. A numeric rating scale can also be 
used for this purpose. Such global 
assessments by the patient, however, do not 
address the different dimensions of health 
status in detail. Health status instruments are 
more appropriate. They comprise items on 
physical, social and emotional functions in 
more or less detail, depending on which in- 
strument is used. In rheumatology, functional 
ability and health status instruments can be 
divided in generic and arthritis specific 
classifications, indexes or instruments (Table 
2). 
Arthritis specific instruments are primarily 
developed for use in patients with rheumatic 
125 
diseases, but generic instruments can be ap- 
plied in patients with rheumatic diseases too. 
Arthritis specific functional ability and health 
status instruments focus on arthritis specific 
consequences of disease e.g. in terms of 
disability and handicap (Fig. 1). Generic 
health status instruments have the advantage 
that they can be used in groups of patients 
with various disease entities, facilitating com- 
parisons among different disease groups. Fur- 
thermore, the chance of missing effects in 
dimensions that are not included is less in 
generic than in arthritis specific instruments. 
An important drawback of generic in- 
struments however, is that they lack specitici- 
ty in populations with rheumatic diseases. 
Specificity may be low, because these in- 
struments not only address dimensions of 
arthritis, but also comprise questions in areas 
that are usually not affected by rheumatic 
diseases, such as incontinence and vision. 
Furthermore symptoms are sometimes more 
heavily weighted than functional categories: a 
bed-ridden arthritic patient could be rated 
higher in physical health than a patient who 
can walk with a cane, depending on these pa- 
tients’ symptoms, specific impairments and 
social support. Also sensitivity may be low 
since areas that are indeed important deter- 
minants of functional ability and health status 
of rheumatic patients, such as mobility and 
tine hand function, are either not included or 
only superficially covered by some generic in- 
struments. 
Which are the Properties of Frequently used In- 
struments? 
Requirements of functional ability and 
health status instruments are reliability-that is 
that they must produce the same results under 
repeated use under the same conditions- and 
validity (Bombardier and Tugwell, 1983). 
Face validity is present if the instrument 
seems to cover the full range of relevant 
topics; construct validity is concerned with 
the relations of the instrument with other 
more established measures. The latter is in- 
vestigated determining the extent of agree- 
ment with laboratory or clinical measures of 
severity of disease or determining the ability 
of the instrument to distinguish between 
groups of patients with different levels of 
health status. For the use in clinical trials, sen- 
sitivity to change of the instrument is a prere- 
quisite. The properties of frequently used 
instruments are specified in Table 3. Most of 
the instruments have been sufficiently 
evaluated for validity, that is that they do 
measure what they are supposed to, and reli- 
ability or reproducibility. Sensitivity to detect 
change is in general less frequently in- 
vestigated (American College of Rheuma- 
tology, 1988, Liang et al., 1983, Bombardier 
and Tugwell, 1983, Bell et al., 1990). Of the in 
Table 2 and 3 listed instruments, only of the 
ARA functional classification, reliability and 
validity are unknown. This global classitica- 
tion is probably not sensible to small changes 
in functional capacity, but it is useful- and fre- 
quently used-for the purpose of classifying pa- 
tients at entry into clinical trials and 
describing the global functional consequences 
of RA (Steinbrocker et al., 1949). Recently, a 
revised and improved version of the ARA 
classification of global functional status, that 
can be used for the same purposes, has been 
developed and validated (Hochberg et al., 
1992); see Table 4 for comparison of the ‘old’ 
and ‘new’ versions. 
The most widely used arthritis specific 
functional ability and health status in- 
struments are the Arthritis Impact Measure- 
ment Scales (AIMS) and the Health 
Assessment Questionnaire (HAQ). Therefore 
these instruments are described in more detail. 
The AIMS1 (formerly called AIMS, until 
AIMS2 were introduced) have been 
developed by Meenan and co-workers at 
Boston University (Meenan et al., 1980, 
1984). This self-assessment questionnaire con- 
sists of 66 items on physical, psychological 
and social aspects and medication usage, com- 
orbidity and demographics (Table 5). An item 
like: Can you prepare a meal? can score one 
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Table 3. Properties of functional ability & health status instrumentsa. 
Assessment of Health Dimensions 











































‘See Table 2 for full names and references; the list is not intended to be complete. 
bIA, interviewer assessment; SR, self report; CJ, clinical judgment; OP, observed performance. 
Table 4. A comparison of the ARA 1949 classification (Steinbrocker) and the ACR 1991 revised criteria of 
global functional status in rheumatoid arthritis (Steinbrocker et al., 1949; Hochberg et al., 1992)‘. 
ACR 199 1 Classification ARA 1949 Classification 
Class I 
Completely able to perform usual activities of daily liv- 
ing: self-care, vocational (work, school, homemaking) and 
avocational (recreational and leisure) 
Class II 
Able to perform usual self-care and vocational 
activities, but limited in avocational activities 
Class III 
Able to perform usual self-care activities, but limited in Functional capacity adequate to perform only few or none 
vocational and avocational activities of the duties of usual occupation or of selfcare 
Class IV 
Limited in ability to perform usual self-care, vocational, 
and avocational activities 
Complete functional capacity with ability to carry on all 
usual duties without handicaps 
Functional capacity adequate to conduct normal 
activities despite handicap of discomfort or limited mobili- 
ty of one or more joints 
Largely or wholly incapacitated with patient bedridden 
or confined to wheelchair, permitting little or no selfcare 
aIn contrary to the ‘old’ ARA criteria, the ‘new’ ACR criteria have been validated. 
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Table 5. The Arthritis Impact Measurement Scales 1 (AIMSI), 
long versus short version’. 
1. MobiIIty (2: a+d) 
a. Travelling around com- 
munity 
b. Using public transpor- 
tation 
c. Having to stay indoors 
d. Being bed or chair 
bound 
6. Act. of Daily Life (2: 
a+b) 
a. Assistance in taking 
bath, shower 
b. Assistance in getting 
dressed 
c. Assistance in using the 
toilet 
2. Physical Activity 
(2: b+d) 
d. Being able to move 
around 
a. Vigorous activities 7. Pain (2: a+b) 
b. Walking blocks, flights a. Grading pain 
of stairs b. Frequency of severe 
c. Bending, lifting, stoop- pain 
ing c. Duration of morning 
d. Going one block, one stiffness 
flight of stairs d. Frequency of pain in 
e. Walking assistance L 2 joints 
3. Dexterity (2: b+d) 8. Depression (2: b+c) 
a. Writing with pen a. Enjoying things 
b. Buttoning clothing b. Being in low spirits 
c. Turning a key c. Being downhearted 
d. Tying shoes d. Things not turning out 
e. Opening a new jar well 
4. Household Activity (2: 
e. others being 
b+c) 
better off you being 
a. Shopping 
dead 
b. Preparing meals 
f. Nothing cheering up 
c. Doing housework 
d. Doing laundry 
e. Taking medication 
f. Handling money 
g. Using telephone 
5. Social Activity (2: a+c) 
a. Getting together with 
friends 
b. Visits from friends 
c. Visiting friends 
d. Being on the phone 
with friends 
9. Anxiety (2: d+e) 
a. Feeling tense 
b. Nervousness 
c. Trying to calm down 
d. Feeling relaxed 
e. Feeling peaceful 
f. Being able to relax 
10. Health Perceptions (0) 
a. Easily getting sick 
b. Worrying about health 
c. Resistance to illness 
d. Catching an illness 
11. Arthritis Impact (0) 
a. Grading impact of 
arthritis 
“All items of AIMSl; items of short version are be- 
tween parentheses. The AIMS1 questionnaire further- 
more contains three items concerning health status, used 
as validation questions and one item about medication 
usage, three about co-morbidity and nine about 
demographics. The total number of items is 66. The 
scales of the DUTCH-AIMS are analogous to those of 
AIMSl. 
to three points (“without any help” one point, 
“with some difficulty” two points, “unable to 
do” three points). The first 53 items are con- 
verted into 11 scales with a range from 0 to 10: 
Mobility, Physical Activity, Dexterity, 
Household Activity, Social Activity, Activi- 
ties of Daily Life, Pain, Depression, Anxiety, 
Health Perceptions (this scale is used for vali- 
dation purposes only) and Arthritis Impact. 
The AIMS1 have been translated in many 
languages; the Dutch version is called the 
DUTCH-AIMS (Taal et al., 1989, Jacobs et 
al., 1992). The scales of the DUTCH-AIMS 
are analogous to those of AIMSl. Several 
modified versions of the AIMS1 exist. In the 
Netherlands also a modified AIMS is used 
(Huiskes et al., 1990). The GERI-AIMS have 
been evaluated for use in geriatric populations 
(Wallston et al., 1989); in this instrument, to 
every item of AIMS1 that assesses functional 
ability, a question has been added, whether 
the patient attributes the self-reported prob- 
lem to arthritis or to other causes. A short 
version of the AIMS1 has been introduced 
too, that performs well (Hughes et al., 1991). 
The items of the AIMS1 and the short AIMS 
are listed in Table 5. Recently, the AIMS1 
were revised, expanded and validated; the 
resulting questionnaire is called AIMS2 
(Meenan et al., 1992). New names were given 
to the revised scales, in order to avoid confu- 
sion with the scales in the AIMS1 version. Of 
all 78 items, the first 57 items are broken 
down in 12 scales: Mobility level, Walking 
and bending, Hand and linger function, Arm 
function, Self-care, Household tasks, Social 
activities, Support from family and friends, 
Arthritis pain, Work, Level of tension and 
Mood (Table 6). Item 58, the scale Satisfac- 
tion, ascertains patients’ satisfaction with 
each of these 12 scales. Item 59 asks the 
respondents to estimate how much of the 
problem with any of the areas of the 12 scales 
is attributable to arthritis; this item allows 
scale scores to be adjusted if problems in a 
particular area are (also) due to disorders 
other than arthritis. Item 60 asks the patient 
to prioritize the three areas in which he or she 
would most like to see improvement. Items 
61-65 assess general perceptions of current 
and future health; from item 61 the Health 
Perceptions scale is formed and from item 66 
Table 6. The Arthritis Impact Measurement Scales 2 
(AIM!32)“. 
1. Mobility Level 7. Social Activity 
a. Using car, public trans- a. Getting together with 
portation friends 
b. Being out of the house b. Visits from friends 
c. Doing errands c. Visiting friends 
d. Assistance in going d. Being on the phone with 
outdoors friends 
e. Being bed or chair e. Going to meetings 
bound 8. Support from Family 
2. Walking and Bending a. Familyaroundfor 
a. Vigorous activities assistance 
b. Walking blocks, flights b. Family sensitive foryour 
of stairs needs 
c. Bending,lifting, stooping c. Familyinterestedinyour 
d. Going one block, one problems 
flight of stairs d. Family understanding 
e. Walking assistance effects of arthritis 
3. Hand and Finger 9. Arthritis Pain 
Function a. Grading pain 
a. Writing b. Frequency of severe pain 
b. Buttoning clothing c. Frequency of pain in 2 
c. Turning a key joints 
d. Tying a knot or bow d. Frequency of morning 
e. Opening a new jar stiffness 
4. Arm Function e. Sleep disturbance by 
a. Wiping mouth with pain 
napkin 10. Work 
b. Putting on pullover a. Main form of work 
c. Combing, brushing hair b. Frequency of being 
d. Scratching low back unable to work 
e. reaching above the head c. Working a shorter day 
5. Self Care d. Quality of performed 
a. Assistance in taking work 
bath, shower e. Adaptations in doing 
b. Assistance in getting the work 
dressed 11. Level of Tension 
c. Assistance in using the a. Feeling tense 
toilet b. Nervousness 
d. Assistance in going in/ c. Being able to relax 
out of bed d. Feeling relaxed 
6. Household Tasks e. Feeling peaceful 
a. Shopping 12. Mood 
b. Preparing meals a. Enjoying things 
c. Doing housework b. Being in low spirits 
d. Doing laundry c. Things not turning out 
well 
d. Others better off you 
being dead 
e. Nothing cheering up 
aThe first 57 items of AIMS2 that are broken down in 
12 scales (Meenan et al., 1992). The AIMS2 furthermore 
contain the scales Satisfaction, Health Perceptions and 
Arthritis Impact: see description in the text. 
Table 7. The HAQ disability index - the eight 
categoriesa with key words, describing the individual items. 
1. Dressing and Grooming 
?? Dressing including 
shoelaces and buttons 
?? Shampoo hair 
2. Arising 
?? Stand up from chair 
?? Get in of out bed 
3. Eating 
0 Cut meat 
?? Lift cup to mouth 
?? Open new milk carton 
4. Walking 
?? Walk outdoors 
?? Climb five steps 
5. Hygiene 
?? Wash & dry body 
?? Take tube bath 
?? Get on and off toilet 
aFor each of the eight categories, the score is the highest 
score of the individual items of that scale. Each item scores 
as follows: 0: ‘without any difficulty’, 1: ‘with some dif- 
ficulty’, 2: ‘with much difticulty’, 3: ‘unable to do’. For 
each category, the use of aids, devices or help from 
another person are checked; if needed for an activity, the 
score of the category is at least 2. Of all category scores, 
the mean is taken. So for this index, an overall score from 
0 to 3 on a continuous scale is produced. 
6. Reach 
?? Get object from 
above head 
?? Bend to pick up from 
floor 
7. Grip 
?? Open car doors 
0 Open jars 




?? Get in and out car 
?? Do chores as 
vacuuming or 
yardwork 
the scale Arthritis Impact. The other items 
deal with the type and duration of arthritis, 
medication usage, comorbidity and 
demographics. It takes about 23 min to com- 
plete this questionnaire, that - like the 
AIMS1 - can be used in RA and osteoar- 
thritis too. 
The HAQ is a self-administered question- 
naire that was developed at Stanford Univer- 
sity (Fries et al., 1980). It measures four 
dimensions in 330 items: disability, discom- 
fort, drug side effects and dollar costs. The 
disability scale, that contains only 24 items 
and takes about 5 min to answer, is most 
widely used (Table 7). Pincus developed a 
modified version with eight instead of 24 
questions on functional ability, adding scales 
on functional change, patient satisfaction and 
pain (Pincus et al., 1983). Reliability and va- 
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Table 8. Frequency in which each endpoint measure was used in the 32 clinical trials on the effectiveness of long-acting 
anti-rheumatic drugs in patients with rheumatoid arthritis, published from 1986 through 1990p. 
Endpoint measure Short-term trialsb Long-term trialsb All trials 
(n= 11) (n = 21) (n = 32) 
% n % n % n 
Morning stiffness 100 11 86 18 91 29 
Pain 91 10 67 14 15 24 
Patient’s global assessment 13 8 71 15 72 23 
Physician’s global assessmentC 64 7 43 9 50 16 
Joint countd 91 10 95 20 94 30 
Joint swellingd 13 8 62 13 66 21 
PIP circumference 46 5 24 5 31 10 
Grip strength 91 10 90 19 91 29 
Walking time’ 55 6 14 3 28 9 
Functional ability 55 6 38 8 44 14 
Health status 18 2 10 2 13 4 
Other clinical endpoints 18 2 24 5 22 I 
ESR 91 10 86 18 88 28 
CRP 27 3 33 I 31 10 
Other laboratory endpoints 13 8 51 12 63 20 
Radiographs’ 18 2 48 10 38 12 
Cost/effectiveness analysis 9 1 0 0 3 1 
a Controlled clinical trials, published in English, searched using a CD-ROM computerized bibliography (Van der Heide 
et al., 1992). 
bShort-term: 24 weeks or less; long-term: more than 24 weeks 
‘No results reported in 1 trial 
dTender and swollen joint counts: number of inflamed joints, in some cases weighted for severity 
lidity of this questionnaire are comparable to 
that of the original HAQ (American College 
of Rheumatology, 1988). The so-called transi- 
tional questions of this modified HAQ, asking 
the patient to grade the degree of change in 
difficulty in accomplishing the specific task 
compared with three months ago, proved to 
be more sensitive to change than the conven- 
tional HAQ questions (Ziebland et al., 1992). 
Like the AIMSl, the HAQ has been 
translated in many languages and several 
modified versions are available. The British 
version is similar to the disability index of the 
HAQ, with only minor changes to the 
phraseology (Kirwan and Reeback, 1986); 
other versions have somewhat more changes 
to the items (Siegert et al., 1984, Van der Heij- 
de et al., 1990, Bijlsma et al., 1990). 
How Often - To Date - are Functional Abili- 
ty and Health Status Instruments Used in 
Clinical Rheumatological Trials and What is 
Their Value? 
In a review of 32 reports of clinical trials, 
published in peer reviewed literature from 
1986 to 1990, in which the effect of disease 
modifying anti-rheumatic drugs (DMARDs) 
was studied, the impact of the applied effect 
parameters was analyzed (Van der Heide et 
al., 1992). The frequency in which different 
outcome variables were used in these trials is 
given in Table 8. Health status instruments 
that measure physical as well as psychological 
and/or social dimensions are used in only 13% 
of the reviewed trials. Functional ability 
separately is measured somewhat more fre- 
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Table 9. Frequency in which statistically signifi- 
cant differences between groups were found for each 
endpoint measure, in trials that report differences in 
effkacy of the investigated drugs (n = 13)‘. 
Endpoint 
measure 
Number of frequency of 
studies, in significant 
which the differences 
the endpoint (“XI of n) 
was used 
Morning stiffness 11 21 
Pain 9 56 
Patient’s global 10 30 
assessment 
Physician’s global 9 44 
assessment 
Joint count 12 58 
Joint swelling 8 63 
PIP circumference 6 17 
Grip strength 11 36 
Walking time 6 17 
Functional ability 6 67 
Health status 3 100 
ESR 10 56 
CRP 3 67 
Radiographs 4 75 
‘Subset of the 32 controlled clinical trials, published in 
English, on the effectiveness of long-acting anti- 
rheumatic drugs in patients with rheumatoid arthritis, 
published from 1986 through 1990, that were found 
using a CD-ROM computerized bibliography (Van der 
Heide et al., 1992). Only the trials that report data on 
between group statistical analyses of mean or median 
endpoint values or mean or median changes are includ- 
ed; eight of these 13 trials are placebo controlled 
quently: in 14 of the 32 trials functional ability 
is an outcome measure. In 10 of these 14 trials 
the investigators used the HAQ disability 
scale or one of its modified versions. 
The relative impact of each of the effect 
parameters on conclusions about the effec- 
tiveness of a DMARD is given in Table 9. The 
frequency in which statistically significant dif- 
ferences between groups were found for 
health status measurement, in trials that re- 
port differences in efficacy of the investigated 
anti-rheumatic drugs, is relatively high, 
although it was used in only three of these 13 
trials. The power of functional ability 
measurements to distinguish between dif- 
ferent treatment is relatively high too. The 
conclusion is therefore, that although func- 
tional ability and health status have not been 
used in clinical RA trials as an evaluation par- 
ameter very frequently yet, their sensitivity to 
detect change seems to be considerable, 
although the grade of sensitivity might differ 
between the instruments. 
Conclusions and Directions for the Future 
Measuring functional ability and health 
status in patients with chronic rheumatic 
diseases can be useful in clinical trials. How- 
ever, it is not standard yet in this setting. 
There are many arguments that it should be 
used more often. In clinical practice, measure- 
ment of functional ability and health status is 
probably useful too in monitoring the follow- 
up of patients, assessing the efficacy and side 
effects of anti-rheumatic drugs. 
The use of well known validated in- 
struments is recommended. Two of the most 
extensively validated and commonly used in- 
struments are the Stanford Health Assessment 
Questionnaire and the Arthritis Impact Mea- 
surement Scales, but in general the other in- 
struments are validated too. The choice of a 
functional ability or health status instrument 
should further be determined by the content 
of the instrument. The instrument that reflects 
best the areas of interest should be chosen. 
There is no need to reinvent the wheel and 
construct one more new instrument. In non 
English speaking patients, the advantage of 
the use of a (translated and validated version 
of an) international well known instrument in 
comparison with a national questionnaire is 
that it is generally known and therefore more 
easy to interpret. Comparison of populations 
of patients with rheumatic diseases between 
different countries can thus be facilitated. 
In rheumatological health care with many 
chronic disabled patients the old adage 
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‘primum est non nocere’, meaning that the 
first principle is not to do harm, should be the 
keystone of our therapeutic interventions. 
Health status can be beneficial but also 
deleteriously influenced by therapeutic in- 
terventions, and side-effects can not always 
clearly be defined by the patients. From this 
point of view, the assessment of health status 
in clinical practice and clinical or observa- 
tional studies, in order to detect ill defined 
side-effects too, is essential. 
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